近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Lyu N, Kong Y, Mu L, Deng H, Li S, Xie Q, Guo R, Shi M, Xu L, Wu P, Zhao M (通讯作者) Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil plus Leucovorin in Hepatocellular Cancer with Extrahepatic Spread；Journal of Vascular and Interventional Radiology 2018 9 accepted （IF 2.76） 2.Li S, Han X, Lyu N, Xie Q, Deng H, Mu L4, Pan T, Huang X, Wang X, Shi Y, Zhao M,(通讯作者). Mechanism and prognostic value of indoleamine-2,3-dioxygenase 1 expressed in hepatocellular carcinoma Cancer Science. 2018:109 :3726–3736（IF 4.37） 3.赵明 李少龙，吕宁 肝癌介入治疗研究进展（综述），中国临床肿瘤学进展（CSCO） P 174-177 人民卫生出版社 2018-9 4.Mu LW，Pan T , Zhao Ming (通讯作者). CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium lung cancer. 122(2018) 25-31（IF 4.5） 5.Lyu N, Kong Y, Mu L, Lin Y, Li J, Liu Y, Zhang Z, Zheng L, Deng H, Li S, Xie Q, Guo R, Shi M, Xu L, Cai X, Wu P, Zhao M (通讯作者). Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.J Hepatol. 2018 Jul;69(1):J Hepatol. 2018 Jul;69(1):60-69. (IF 15.04) 6.Lyu N, Lin YE, Kong YN,Zhang ZF,Liu LZ, Zheng L, Mu LW, Wang JP, Li XS,Pan T, Xie QK, Liu YR, Lin AH, Wu PH, Zhao Ming (通讯作者). FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/ leucovorin for advanced hepatocellular carcinoma Gut February 2018 Vol 67 No 2 395-397（IF 17.01） 7.Mu LW, Sun L, Pan T, Lyu N, Li SL, Li XS,Wang JP, Xie QK, Deng HJ, Zhen L, Peng JH,Shen LJ, Fan WJ, Wu PH, Zhao Ming (通讯作者). Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results International Journal of Hyperthermia 2018;34(1):59-67.（IF 3.4） 8.Pan T, Mu LW, Wu C, Wu XQ, Xie QK, Li XS, Lyu N, Li SL, Deng HJ, Jiang ZB, Lin AH, Zhao Ming (通讯作者). Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study. Journal of Cancer 2017; 8(17):3506-3513（IF 3.2） 9.Qiu B, Liang Y, Li Q， Liu G, Wang F, Chen Z, Liu M, Zhao Ming (共同通讯) Liu H. Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation. Clin Lung Cancer. 2017 Nov;18(6):e369-e373（IF 3.4） 10.Pan T, Xie QK, Lv N, Li XS, Mu LW, Wu PH, Zhao Ming (通讯作者). Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score-matching Analysis. Radiology. 2017 Jan;282(1):259-270.S1525-7304(17)30107-9.（IF 7.4） 11.Xie QK, Zhao YJ, Pan T, Lyu N, Mu LW, Li SL, Shi MD, Zhang ZF, Zhou PH, Zhao Ming (通讯作者). Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma. Oncoimmunology. 2016 May 13;5(7):e1181252. （IF 5.5） 12.Lv N, Kong YN, Mu LW, Pan T, X QK, Zhao Ming (通讯作者). Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial Eur Radiol 2016 Oct;26(10):3492-9. （IF 4.0） 13.Pan T, Li XS, Xie QK, Wang JP, Li W, Wu PH, Zhao Ming (通讯作者). Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. Clinic Radiology. 2014 Dec; 69(12):e 553-61.（IF 2.5） 14.Li X, Zhao Ming (通讯作者) Wang J, Fan W, Li W, Pan T, Wu P: Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. Am J Roentgenol.2013;201(6):1362-7.（IF 2.8） 15.Lin JQ, Zhao XX, Zhi QQ, Zhao Ming (共同通讯) He ZM: Transcriptomic profiling of Aspergillus flavus in response to 5-azacytidine. Fungal Genet Biol. 2013;56:78-86.（IF 3.1） 16.Chen YY, Shen HJ, Cui YY, Chen SG, Weng ZM, Zhao Ming (共同通讯), Liu JZ: Chromosomal evolution of Escherichia coli for the efficient production of lycopene. BMC Biotechnol 2013, 13(1):6 （IF2.4） 17.Zhao Ming (通讯作者), Wang JP, Pan CC, Li W, Huang ZL, Zhang L, Fang WJ, Jiang Y, Li XS, Wu PH: CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement. Eur J Radiol 2012, 81(10):2717-2725.（IF 2.5） 18.Pan CC, Wu PH, Yu JR, Li W, Huang ZL, Wang JP, Zhao Ming (通讯作者). Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation. Eur J Radiol 2012, 81(4):e473-e477.（IF 2.5） 19.Li X, Wang J, Li W, Huang Z, Fan W, Chen Y, Shen L, Pan T, Wu P, Zhao Ming (通讯作者): Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. International Journal of Hyperthermia 2012;28:721-728. （IF 3.4） 20.Zhao Ming (通讯作者). Li X, Wang J, Li W, Huang Z: Retroperitoneal schwannoma treated with percutaneous computed tomography-guided radiofrequency ablation. J Neurosurg Spine 2012, 17(2):173-176.（IF 2.76）
京公网安备 11010802027423号